BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹86 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 3.65 | |
| Mar2024 | ₹148 Cr | 13.97 | |
| Mar2023 | ₹130 Cr | 43.75 | |
| Mar2022 | ₹90 Cr | 4.25 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹634.7 Cr | 7.7% | 15% | 231.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7.7% |
15% |
231.2% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses